Interestingly, blocking IL-1β signaling with an IL-1 receptor antagonist normalized synaptic transmission and plasticity [10,15], confirming the specific role of IL-1β as a key player of inflammatory synaptopathy in EAE and MS. This evidence concerns the gene IL1B and myeloid sarcoma.